Angiotech: In No Hurry To Take Out Orthovita

Cohen, Judy Radler
June 2005
Mergers & Acquisitions Report;6/20/2005, Vol. 18 Issue 24, p1
Reports on the decision of U.S. firm Angiotech Pharmaceuticals Inc. to delay its plan of acquiring Orthovita Inc. following the rejection of its offer by Orthovita Inc. Cash offer made by Angiotech Pharmaceuticals Inc.; Analysis of the merger and acquisition tactics of Angiotech Pharmaceuticals; Business operations of the two companies.


Related Articles

  • Deals roundup.  // Medical Device Daily;11/19/2010, Vol. 14 Issue 226, p2 

    The article reports on the acquisition of the Lifespan Vascular Graft manufacturing business of Angiotech Pharmaceuticals by LeMaitre Vascular.

  • Argon Medical Devices Buys Angiotech's Interventional Biz.  // Medical Product Outsourcing;Apr2013, Vol. 11 Issue 3, p12 

    The article offers information on acquiring of business related to interventional products of Angiotech Pharmaceuticals Inc. by the Argon Medical Devices Inc.

  • Styker completes $316M acquisition of Orthovita.  // Medical Device Daily;6/30/2011, Vol. 15 Issue 121, p2 

    The article announces the acquisition of Orthovita based in Pennsylvania by Michigan-based orthopedic device-maker Stryker.

  • UPDATE: Stryker Acquires Orthovita. Cody, Tamika // Mergers & Acquisitions Report;5/23/2011, Vol. 24 Issue 21, p23 

    The article deals with the acquisition of the common stocks owned by U.S. orthobiologics platform developer Orthovita by medical equipment and device developer Stryker Corp. in May 2011.

  • CORPORATE.  // MondayMorning;3/9/2009, Vol. 17 Issue 9, p2 

    The article offers news briefs related to the pharmaceutical industry. The U.S. Supreme Court allowed patients to sue drugmakers who fail to provide adequate safety warnings, after a musician lost her arm after being injected with Wyeth's Phenergan nausea treatment. Vertex Pharmaceuticals Inc....

  • Other News To Note.  // BioWorld Today;5/3/2011, Vol. 22 Issue 85, p2 

    This section offers news briefs about the biopharmaceutical industry. An application was filed by Angiotech Pharmaceuticals Inc. with Canadian securities regulatory authorities to cease being a reporting issuer. Cell Therapeutics Inc. retired its outstanding 7.5% convertible senior notes by...

  • Angiotech Pharmaceuticals, Inc. ANPI. Stralow, Julie // Morningstar GrowthInvestor;Oct2007, Vol. 3 Issue 5, p7 

    The article focuses on the performance of the stocks of pharmaceutical firm Angiotech Pharmaceuticals Inc. as an emerging moat company. The BSX drug-eluting Taxus stent from its partner company Boston Scientific, a device manufacturer, is said to be the company's first hit with $2 billion in...

  • SWOT Analysis.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;May2007, p5 

    A business analysis of Angiotech Pharmaceuticals Inc. (Angiotech), a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company....

  • infostop.  // Medical Device Technology;Jan/Feb2004, Vol. 15 Issue 1, p86 

    Reports on the agreement of strategic alliance for developing innovative products by mnemoScience and a subsidiary of CR Bard Inc. Acquisition of privately owned STS Biopolymers by the Angiotech Pharmaceuticals; Accommodation of company's increased business in purpose-build facilities by...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics